UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
TLSI holding history
TriSalus Life Sciences, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TLSI overviewAll 13F holders of TLSIFull Q2 2026 holdings
- Shares (Q2 2026)
- 223,047
- Value
- $1.01M
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 223,047 | $1.01M | <0.1% | +143,495+180.4% | Added | Holders |
| Q1 2026 | 79,552 | $318.2K | <0.1% | +74,403+1,445.0% | Added | Holders |
| Q4 2025 | 5,149 | $35.9K | <0.1% | −3,829−42.6% | Reduced | Holders |
| Q3 2025 | 8,978 | $41.7K | <0.1% | −7,714−46.2% | Reduced | Holders |
| Q2 2025 | 16,692 | $91.0K | <0.1% | +9,883+145.1% | Added | Holders |
| Q1 2025 | 6,809 | $37.6K | <0.1% | +6,787+30,850.0% | Added | Holders |
| Q4 2024 | 22 | $110 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 22 | $101 | <0.1% | −1,966−98.9% | Reduced | Holders |
| Q2 2024 | 1,988 | $11.0K | <0.1% | +1,597+408.4% | Added | Holders |
| Q1 2024 | 391 | $3.81K | <0.1% | −16,424−97.7% | Reduced | Holders |
| Q4 2023 | 16,815 | $142.1K | <0.1% | −8,117−32.6% | Reduced | Holders |
| Q3 2023 | 24,932 | $127.7K | <0.1% | +24,932 | New | Holders |